Episode 32: Risk-Based Quality Management in CDM episode artwork

EPISODE · Feb 6, 2026 · 11 MIN

Episode 32: Risk-Based Quality Management in CDM

from QCast: Data-Driven Dialogue in Drug Development · host Quanticate

In this QCast episode, Jullia and Tom unpack risk-based quality management (RBQM) in clinical data management and why it’s central to protecting participant safety and the reliability of trial results. They clarify what RBQM means in practice, how teams identify critical data and processes, and how KRIs and QTLs can be used to spot emerging issues early and drive proportionate, documented action across functions.Key TakeawaysUnderstand what RBQM is in a clinical data management context, and how it focuses oversight on critical-to-quality data and processes.Learn how KRIs and QTLs are used day to day, including how to avoid 'metric noise'. Apply practical steps to keep RBQM effective through delivery when risks span data management and operations.🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial. 📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.About QuanticateFounded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:Clinical Data Capture & ManagementBiostatistics & Statistical ConsultancyStatistical Programming & PK/PD AnalysisMedical Writing & PharmacovigilanceRegulatory & Submission SupportAI & AutomationPost-Marketing Safety & Real-World DataQuanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

Episode metadata supplied by the publisher feed · Published Feb 6, 2026

Embed this episode

In this QCast episode, Jullia and Tom unpack risk-based quality management (RBQM) in clinical data management and why it’s central to protecting participant safety and the reliability of trial results. They clarify what RBQM means in practice, how teams identify critical data and processes, and how KRIs and QTLs can be used to spot emerging issues early and drive proportionate, documented action across functions. Key Takeaways Understand what RBQM is in a clinical data management context, and...

Distinct summary based on available episode metadata or transcript content.

Ready to play

Episode 32: Risk-Based Quality Management in CDM

0:00 11:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of QCast: Data-Driven Dialogue in Drug Development?

This episode is 11 minutes long.

When was this QCast: Data-Driven Dialogue in Drug Development episode published?

This episode was published on February 6, 2026.

Can I download this QCast: Data-Driven Dialogue in Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!